PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2

Wei Wang, Fang Gu, Cai Wei, Yigui Tang, Xin Zheng, Mingqiang Ren, Yide Qin

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Bioactive peptides, either derived from nature resources or synthesized by rational design, have been demonstrated potential for therapeutic agents against numerous human diseases, including cancer. However, the mechanism of therapeutic peptides against cancer has not been well elucidated. Here we show that PGPIPN, a hexapeptide derived from bovine β-casein, inhibited the proliferation of human ovarian cancer cells line SKOV3 as well as the primary ovarian cancer cells in vitro. Consistently, PGPIPIN also decreased tumor growth rate in xenograft ovarian cancer model mice in a dose-dependent manner. Further study demonstrated that the anti-tumor effect of PGPIPN is partially through promoting cell apoptosis by inhibiting BCL2 pathway. Thus, our study suggests that PGPIPN is a potential therapeutic agent for the treatment of ovarian cancer or other types of cancer.

Original languageEnglish (US)
Article numbere60701
JournalPloS one
Volume8
Issue number4
DOIs
StatePublished - Apr 8 2013

Fingerprint

ovarian neoplasms
Ovarian Neoplasms
Tumors
Cells
therapeutics
Peptides
neoplasms
Growth
Caseins
Heterografts
Neoplasms
Apoptosis
peptides
Therapeutics
human diseases
casein
apoptosis
animal models
cell lines
Cell Line

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2. / Wang, Wei; Gu, Fang; Wei, Cai; Tang, Yigui; Zheng, Xin; Ren, Mingqiang; Qin, Yide.

In: PloS one, Vol. 8, No. 4, e60701, 08.04.2013.

Research output: Contribution to journalArticle

Wang, Wei ; Gu, Fang ; Wei, Cai ; Tang, Yigui ; Zheng, Xin ; Ren, Mingqiang ; Qin, Yide. / PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2. In: PloS one. 2013 ; Vol. 8, No. 4.
@article{7113d53e1b6745bf960c330c2bdccf13,
title = "PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2",
abstract = "Bioactive peptides, either derived from nature resources or synthesized by rational design, have been demonstrated potential for therapeutic agents against numerous human diseases, including cancer. However, the mechanism of therapeutic peptides against cancer has not been well elucidated. Here we show that PGPIPN, a hexapeptide derived from bovine β-casein, inhibited the proliferation of human ovarian cancer cells line SKOV3 as well as the primary ovarian cancer cells in vitro. Consistently, PGPIPIN also decreased tumor growth rate in xenograft ovarian cancer model mice in a dose-dependent manner. Further study demonstrated that the anti-tumor effect of PGPIPN is partially through promoting cell apoptosis by inhibiting BCL2 pathway. Thus, our study suggests that PGPIPN is a potential therapeutic agent for the treatment of ovarian cancer or other types of cancer.",
author = "Wei Wang and Fang Gu and Cai Wei and Yigui Tang and Xin Zheng and Mingqiang Ren and Yide Qin",
year = "2013",
month = "4",
day = "8",
doi = "10.1371/journal.pone.0060701",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - PGPIPN, a Therapeutic Hexapeptide, Suppressed Human Ovarian Cancer Growth by Targeting BCL2

AU - Wang, Wei

AU - Gu, Fang

AU - Wei, Cai

AU - Tang, Yigui

AU - Zheng, Xin

AU - Ren, Mingqiang

AU - Qin, Yide

PY - 2013/4/8

Y1 - 2013/4/8

N2 - Bioactive peptides, either derived from nature resources or synthesized by rational design, have been demonstrated potential for therapeutic agents against numerous human diseases, including cancer. However, the mechanism of therapeutic peptides against cancer has not been well elucidated. Here we show that PGPIPN, a hexapeptide derived from bovine β-casein, inhibited the proliferation of human ovarian cancer cells line SKOV3 as well as the primary ovarian cancer cells in vitro. Consistently, PGPIPIN also decreased tumor growth rate in xenograft ovarian cancer model mice in a dose-dependent manner. Further study demonstrated that the anti-tumor effect of PGPIPN is partially through promoting cell apoptosis by inhibiting BCL2 pathway. Thus, our study suggests that PGPIPN is a potential therapeutic agent for the treatment of ovarian cancer or other types of cancer.

AB - Bioactive peptides, either derived from nature resources or synthesized by rational design, have been demonstrated potential for therapeutic agents against numerous human diseases, including cancer. However, the mechanism of therapeutic peptides against cancer has not been well elucidated. Here we show that PGPIPN, a hexapeptide derived from bovine β-casein, inhibited the proliferation of human ovarian cancer cells line SKOV3 as well as the primary ovarian cancer cells in vitro. Consistently, PGPIPIN also decreased tumor growth rate in xenograft ovarian cancer model mice in a dose-dependent manner. Further study demonstrated that the anti-tumor effect of PGPIPN is partially through promoting cell apoptosis by inhibiting BCL2 pathway. Thus, our study suggests that PGPIPN is a potential therapeutic agent for the treatment of ovarian cancer or other types of cancer.

UR - http://www.scopus.com/inward/record.url?scp=84875986442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875986442&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0060701

DO - 10.1371/journal.pone.0060701

M3 - Article

C2 - 23593287

AN - SCOPUS:84875986442

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e60701

ER -